VAERS reports by lot

GSK Varicella/Shingles lot 4RR52: VAERS reports

33 VAERS reports list lot 4RR52 as a GSK Varicella/Shingles vaccine, received between 2019-08-17 and 2020-09-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
6%
Marked serious
1
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3825%
Injection-site / Local reaction3020%
Cardiac / Cardiovascular2517%
Dermatological (non-injection-site)2114%
Neurological139%
Allergic / Anaphylactic85%
Respiratory43%
Gastrointestinal43%
Musculoskeletal43%
Thrombotic / Hematological21%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida7
South Carolina4
Georgia4
North Carolina3
Kansas1
Wisconsin1
Idaho1
Ohio1
Washington1
Arkansas1
Iowa1
Oregon1

Reports by month received

2019-0810
2019-0913
2019-103
2019-112
2020-012
2020-022
2020-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.